Perfil
Dr. Andrew King is a President-Research & Development at Jade Biosciences, Inc. and a Chief Scientific Officer at Jade Biosciences, Inc. (United States).
Dr. King was previously employed as a Chief Scientific Officer by Chinook Therapeutics, Inc. and a Senior Director-Discovery & Translational Biology by Ardelyx, Inc. He received his undergraduate degree from Murdoch University and a doctorate degree from Michigan State University.
Cargos activos de Andrew King
| Empresas | Cargo | Inicio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 28/04/2025 |
Antiguos cargos conocidos de Andrew King.
| Empresas | Cargo | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 09/08/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Formación de Andrew King.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Murdoch University
Murdoch University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
- Bolsa de valores
- Insiders
- Andrew King
















